Jagsonpal Pharmaceuticals (India) Price Prediction
| JAGSNPHARM | 616.40 20.25 3.18% |
Oversold Vs Overbought
58
Oversold | Overbought |
Quarterly Earnings Growth 0.496 | Quarterly Revenue Growth 0.292 |
Using Jagsonpal Pharmaceuticals hype-based prediction, you can estimate the value of Jagsonpal Pharmaceuticals Limited from the perspective of Jagsonpal Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Jagsonpal Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Jagsonpal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Jagsonpal Pharmaceuticals after-hype prediction price | INR 632.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Jagsonpal |
Jagsonpal Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Jagsonpal Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Jagsonpal Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Jagsonpal Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Jagsonpal Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Jagsonpal Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Jagsonpal Pharmaceuticals' historical news coverage. Jagsonpal Pharmaceuticals' after-hype downside and upside margins for the prediction period are 554.76 and 637.23, respectively. We have considered Jagsonpal Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Jagsonpal Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Jagsonpal Pharmaceuticals is based on 3 months time horizon.
Jagsonpal Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Jagsonpal Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Jagsonpal Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Jagsonpal Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.74 | 4.33 | 17.02 | 5.07 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
616.40 | 632.96 | 2.69 |
|
Jagsonpal Pharmaceuticals Hype Timeline
Jagsonpal Pharmaceuticals is currently traded for 616.40on National Stock Exchange of India of India. The entity has historical hype elasticity of 17.02, and average elasticity to hype of competition of 5.07. Jagsonpal is forecasted to increase in value after the next headline, with the price projected to jump to 632.96 or above. The average volatility of media hype impact on the company the price is about 18.83%. The price growth on the next news is projected to be 2.69%, whereas the daily expected return is currently at 0.74%. The volatility of related hype on Jagsonpal Pharmaceuticals is about 63.15%, with the expected price after the next announcement by competition of 621.47. Jagsonpal Pharmaceuticals Limited has accumulated 89.41 M in total debt. Assuming the 90 days trading horizon the next forecasted press release will be in about 4 days. Check out Jagsonpal Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Jagsonpal Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Jagsonpal Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Jagsonpal Pharmaceuticals' future price movements. Getting to know how Jagsonpal Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Jagsonpal Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HERITGFOOD | Heritage Foods Limited | 0.00 | 2 per month | 0.00 | (0.20) | 3.40 | (4.99) | 9.86 | |
| COFFEEDAY | Coffee Day Enterprises | 0.00 | 3 per month | 0.00 | (0.24) | 4.99 | (5.02) | 10.03 | |
| ADFFOODS | ADF Foods Limited | 21.95 | 3 per month | 2.71 | 0.04 | 5.74 | (4.16) | 19.18 | |
| TATACHEM | Tata Chemicals Limited | 33.05 | 4 per month | 2.28 | 0 | 3.24 | (3.84) | 13.12 | |
| HNDFDS | Hindustan Foods Limited | 3.05 | 1 per month | 0.00 | (0.21) | 2.82 | (3.22) | 10.78 | |
| UNIVAFOODS | Univa Foods Limited | 0.00 | 1 per month | 0.00 | 0.11 | 0.00 | 0.00 | 4.99 | |
| MEGASTAR | Megastar Foods Limited | (10.05) | 1 per month | 0.00 | (0.11) | 3.74 | (3.78) | 17.89 |
Jagsonpal Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Jagsonpal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Jagsonpal using various technical indicators. When you analyze Jagsonpal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Jagsonpal Pharmaceuticals Predictive Indicators
The successful prediction of Jagsonpal Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Jagsonpal Pharmaceuticals Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Jagsonpal Pharmaceuticals based on analysis of Jagsonpal Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Jagsonpal Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Jagsonpal Pharmaceuticals's related companies.
Story Coverage note for Jagsonpal Pharmaceuticals
The number of cover stories for Jagsonpal Pharmaceuticals depends on current market conditions and Jagsonpal Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Jagsonpal Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Jagsonpal Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Jagsonpal Pharmaceuticals Short Properties
Jagsonpal Pharmaceuticals' future price predictability will typically decrease when Jagsonpal Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Jagsonpal Pharmaceuticals Limited often depends not only on the future outlook of the potential Jagsonpal Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Jagsonpal Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.6 M | |
| Cash And Short Term Investments | 1.5 B |
Complementary Tools for Jagsonpal Stock analysis
When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |